Editoral Board
  Editor
          Tong xiao wen
  Assciate Editor
          Yu junde
  Editoral Board
          Rui-qin Yao
  Expert
    Expert
    Min Kong
    Min Kong

    Personal Information:
    Name: Min Kong
    Gender: Female
    Date of birth: 1978-04
    Place of birth: Qufu, Shandong, China
    Nationality: China
    Marital status: Married
    Department: Department of Neurology, Yantaishan Hospital, Shandong Province, 264000, China
    Address: No.91, Jie fang Road , Yantai City , Shandong Province, China
    E-mail: kk_kmm@sina.com
    Education:
    2006~2009, Ph.D. Shanghai jiaotong University, Shanghai, China
    2002~2005, M.D. Shanghai University of Traditional Chinese Medicine, Shanghai, China
    Employment:
       2016~present   Associate chief physician, Dept. of Neurology, Yantaishan Hospital, Yantai City, Shandong, P.R.China
    2013~present,  Attending doctor, Dept. of Neurology, Yantaishan Hospital, Yantai City, Shandong, P.R.China
    2009~2012,    Resident doctor, Dept. of Neurology, Yantaishan Hospital, Yantai City, Shandong, P.R.China
    Clinical Service Area
    Neurology; Acupuncture and moxibustion
    Specialty
    Movement Disorders
    Parkinson's Disease
    Tremors;
    Focal dystonia;
    Program control of deep brain stimulation
    Hemiplegia after stroke
    All kinds of pain
    Obesity
    Honors and Awards:
    The second prize of Yantai scientific and Technological Progress Award (2015)
    The second prize of Yantai scientific and Technological Progress Award (2013)
    Medical science and technology award of Shanghai City (2009)
    Current Research Interests:
    Clinical study of  effectiveness and safety of rasagiline mesylate orally disintegrating tablets in the treatment of Parkinson’s disease patients with motor fluctuations.
    Mitochondrial mechanism in the Parkinson’s disease and Alzheimer's disease and the related neuroprotective effects.
    Synaptic plasticity and Parkinson’s disease and levodopa-induced motor complications. Focus on NMDA and AMPA signaling complex and synaptic plasticity.
    Clinical study of  effectiveness of deep brain stimulation in the treatment of moderate and advanced Parkinson’s disease.
    Clinical study of  effectiveness of  Botox in the treatment of focal dystonia, such as spasmodic torticollis, facial spasm.
    Clinical study of  effectiveness of  Acupuncture and moxibustion in the treatment of hemiplegia after stroke, all kinds of pain, depression and anxiety, obesity, insomnia, and so on.
    Publications:
    [1] Ba M, Kong M, Ma G. Postsynaptic density protein 95 regulated NR2B tyrosine phosphorylation and interactions of Fyn with NR2B in levodopa-induced dyskinesia rat model. Drug Des Devel Ther.2015, 9:199-206.
    [2] Kong M, Ba M. et.al. NR2B antagonist CP-101,606 inhibits NR2B phosphorylation at tyrosine-1472 and its interactions with Fyn in levodopa-induced dyskinesia rat model. Behavioural Brain Research. 2015, 282:46–53.
    [3]     Kong M, Ba M. Protective effects of diazoxide against Aβ25-35-induced PC12 cell apoptosis due to prevention of endoplasmic reticulum stress. Neuroreport. 2012; 23(8):493-7.
    [4]     Kong M, Ba M, Liang H, Ma L, Yu Q, Yu T, Wang Y. 5’-aza-dC sensitizes paraquat toxic effects on PC12 cell. Neurosci Lett. 2012, 524(1):35-39.
    [5]     Ba M, Kong M, Yu G, et al. GluR1 phosphorylation and persistent expression of levodopa-induced motor response alterations in the Hemi-Parkinsonian rat. Neurochem Res. 2011, 36(6):1135-1144.
    [6]     Kong M, Ba MW (co-first author), Song L, et al. Comparative effects of acute or chronic administration of levodopa to 6-OHDA-lesioned rats on the expression and phosphorylation of N-methyl-D-aspartate Receptor NR1 subunits in the striatum. Neurochem Res. 2009,34:1513–1521.
    [7]     Maowen Ba, Min Kong, Guozhao Ma, et al. Cellular and behavioural effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications. Brain Research. 2007,1127(1):177-184.
    [8]     Maowen Ba, Min Kong, Hongqi Yang, et al. Changes in Subcellular Distribution and Phosphorylation of GluR1 in Lesioned Striatum of 6-OHDA-Lesioned and L-dopa-Treated Rats. Neurochem Res. 2006, 31(11):1337-1347.
    [9]     Maowen Ba, Min Kong. Clinical progress of Parkinson disease and motor complications. Chemical Industry Press. 2012. Peking. ISBN:978-7-122-13553-7.
    [10] Lu Song, Min Kong, Yaping Ma, et al.Inhibitory Effect of 8-(3-chlorostryryl) Caffeine on Levodopa-induced Motor Complications Is Associated with Intracellular Signaling Pathway in 6-OHDA-Lesioned Rats.Brain Research. 2009.
     
    Grants:
    The Young Scholars General Program of National Natural Science Foundation of  Shandong province, China (Project proposal No. ZR2013HQ003). (The first responsible person, 2013-2016).
    Medical science and technology development plans of  Shandong province, China (Project proposal No. 2014WS0260). (The first responsible person, 2014-2016).
    The science and technology development plan item of Yantai city, Shandong province, China (Project proposal No. 2014WS035). (The first responsible person, 2014-2016).

     
     
    Home  | About us  | Journals  | Learn  | Books  | Expert  | Articles  | News  | Contact  | Download  | Flash  | Journals
    © 2016 by International Science and Technology Publishing